Innoviva Inc (INVA)

HEALTH CARE: PHARMACEUTICALS
SIC: PHARMACEUTICAL PREPARATIONS

2000 SIERRA POINT PARKWAY BRISBANE, CA 94005

Develops small molecule medicines for unmet medical needs across a number of therapeutic areas including respiratory disease, bacterial infections, overactive bladder and gastrointestinal disorders. Of its six programs in development as of June 2005, two were in late stage development.

Data based on most recent fiscal year report
Market Cap1.468 Billion Shares Outstanding101.28 Million Avg Volume1.105 Million
1-Yr BETA vs S&P TR0.844 Current Ratio34.92 Quick Ratio34.92

Are you looking for this stock instead?

View SEC Filings from INVA instead.

View recent insider trading info

Funds Holding INVA (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding INVA BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

TYREE JAMES L

  • Director
5,345 2020-01-13 0

SCHLESINGER SARAH J.

  • Director
0 2020-01-06 1

YOUNG WILLIAM D

  • Director
9,311 2020-01-02 0

BICKERSTAFF GEORGE

  • Director
95,657 2020-01-02 3

GLAXOSMITHKLINE PLC

  • Director
  • 10% Owner
12,455,252 2020-01-01 0

VAGELOS P ROY CHAIRMAN OF THE BOARD

  • Officer
  • Director
536,437 2019-12-16 0

WINNINGHAM RICK E CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
1,167,022 2019-11-20 0

SHAFER BRADFORD J EVP, GEN. COUNSEL, SECRETARY

  • Officer
175,334 2019-11-20 0

PASQUALONE FRANK SVP, CHIEF COMM OPS OFFICER

  • Officer
318,312 2019-11-20 0

ZHEN MARIANNE CHIEF ACCOUNTING OFFICER

  • Officer
26,940 2019-11-20 6

LEPORE PATRICK G

  • Director
300,000 2019-11-15 0

DUNCAN BARBARA GAYLE

  • Director
0 2019-11-13 0

KEARNEY TERRENCE C

  • Director
5,811 2019-10-31 0

MAMMEN MATHAI

  • Director
0 2019-09-16 0

HULME GEOFFREY INTERIM PEO

  • Officer
34,500 2019-09-04 4

ABERCROMBIE GEORGE B

31,394 2019-08-31 0

BRINKLEY DAVID L

  • Director
0 2019-07-18 0

LEVINE ARNOLD J

  • Director
0 2019-06-19 0

GUNDERSON ROBERT V JR

  • Director
62,477 2019-04-30 0

MALKIEL BURTON G

  • Director
80,142 2019-04-30 0

WHITESIDES GEORGE M

  • Director
232,613 2019-04-30 0

RINGROSE PETER S

  • Director
37,999 2019-04-30 0

ODYSSEAS KOSTAS D

  • Director
45,161 2019-04-24 1

DIPAOLO MARK

  • Director
41,165 2019-04-24 1

HAIMOVITZ JULES

  • Director
53,365 2019-04-24 1

FRIEDMAN CATHY

  • Director
10,300 2019-02-22 0

WITEK THEODORE J. JR. SR. VP & CHIEF SCIENTIFIC OFF.

  • Officer
247,767 2018-08-20 0

DESPARBES ERIC SVP AND CFO

  • Officer
373,081 2018-05-20 0

BLUM LEONARD M SEE REMARKS

  • Officer
0 2018-05-14 0

FORE HENRIETTA

  • Director
No longer subject to file 2017-12-31 0

AGUIAR MICHAEL W PRESIDENT & CHIEF EXEC OFFICER

  • Officer
  • Director
980,907 2017-12-04 0

FAERM MICHAEL E. SR VP & CHIEF BUSINESS OFFICER

  • Officer
279,422 2017-11-20 0

WALTRIP WILLIAM H

  • Director
161,789 2017-04-20 0

PEPE PAUL

  • Director
73,805 2017-04-20 0

LEE JUNNING SR. VP, TECHNICAL OPERATIONS

  • Officer
234,071 2017-02-20 0

RADLY ADAM E CEO

191,600,227 2014-07-31 0

JONKER JEFFREY DAVID SENIOR VP, CORP. & BUS. DEV.

  • Officer
0 2014-06-03 0

AUNGER PAUL SECRETARY

ADVISORS LLC

  • Officer
  • Director
  • 10% Owner
28,097,122 2012-11-01 0

DRAZAN JEFFREY M

  • Director
33,465 2012-05-01 0

INOVA TECHNOLOGY INC. PRESIDENT

  • Officer
  • Director
35,700,884 2012-01-22 0

KITT MICHAEL SR. VICE PRESIDENT DEVELOPMENT

  • Officer
32,738 2008-06-02 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5
No current insider transactions
Click here to report any possible errors with this stock listing.

Elevate your investments